Inconsistent with the upregulation of ANGPTL4 in plasma among those at risk for cognitive impairment, autopsied AD brains (compared to non-AD control brains) showed reduced ANGPTL4 expression in astrocytes, neurons, cerebrovascular cell types, and meningeal fibroblast. This evidence concerns the gene ANGPTL4 and Alzheimer disease.